| Ytd | 6.78% | |
| 1y | -0.43% |
| Open | 114.58 | Prev Close | 115.55 | Low | 114.50 | High | 116.72 | Mkt Cap | 2.14B |
| Vol | 195.33K | Avg Vol | 234.63K | EPS | 5.66 | P/E | 20.26 | Forward P/E | 15.25 |
| Beta | 0.86 | Short Ratio | 4.43 | Inst. Own | 107.97% | Dividend | N/A | Div Yield | N/A |
| Ex Div Date | N/A | Earning | 11-02 | 50-d Avg | 111.74 | 200-d Avg | 105.47 | 1yr Est | 134.69 |
Addus HomeCare Corporation (ADUS) reached a significant support level, and could be a good pick for
Addus HomeCare Corporation (NASDAQ:ADUS) (the "Company"), a provider of home care services,
FRISCO, Texas--(BUSINESS WIRE)--Addus HomeCare Corporation (Nasdaq: ADUS) (the “Company”), a provide
Investors interested in Medical - Outpatient and Home Healthcare stocks are likely familiar with Add
Empowered Funds LLC lowered its holdings in Addus HomeCare Corporation (NASDAQ: ADUS) by 62.3% durin
RBC Capital analyst Ben Hendrix maintains Addus HomeCare (NASDAQ:ADUS) with a Outperform and rais
Addus HomeCare Corporation (ADUS) Q2 2026 Earnings Call Transcript
Addus HomeCare NASDAQ: ADUS reported second-quarter 2026 revenue growth of 8% and adjusted earnings-
The headline numbers for Addus HomeCare (ADUS) give insight into how the company performed in the qu
Addus HomeCare (ADUS) came out with quarterly earnings of $1.73 per share, beating the Zacks Consens
FRISCO, Texas--(BUSINESS WIRE)--Addus HomeCare Corporation (NASDAQ: ADUS), a provider of home care s
FRISCO, Texas--(BUSINESS WIRE)--Addus HomeCare Corporation (Nasdaq: ADUS), a provider of home care s
Barclays analyst Andrew Mok maintains Addus HomeCare (NASDAQ:ADUS) with a Underweight and raises
ADUS's business model has structural advantages that will allow it to withstand sector-wide pressure
This healthcare provider delivers personal care, hospice, and home health services across 22 states,
Addus HomeCare NASDAQ: ADUS executives said a new federal moratorium on certain home health licenses
Citizens analyst Constantine Davides reiterates Addus HomeCare (NASDAQ:ADUS) with a Market Outper
Barclays analyst Andrew Mok maintains Addus HomeCare (NASDAQ:ADUS) with a Underweight and lowers
https://www.cms.gov/newsroom/press-releases/cms-announces-aggressive-nationwide-crackdown-fraud-six-
Addus HomeCare Corporation (ADUS) Presents at Bank of America Global Healthcare Conference 2026 Tran
Citizens analyst Constantine Davides maintains Addus HomeCare (NASDAQ:ADUS) with a Market Outperf
Addus HomeCare Corporation (ADUS) Q1 2026 Earnings Call Transcript
FRISCO, Texas--(BUSINESS WIRE)--Addus HomeCare Corporation (Nasdaq: ADUS), a provider of home care s
Addus HomeCare (ADUS) came out with quarterly earnings of $1.62 per share, beating the Zacks Consens
Although the revenue and EPS for Addus HomeCare (ADUS) give a sense of how its business performed in
Addus HomeCare (NASDAQ:ADUS) reported quarterly earnings of $1.62 per share which beat the analyst c
FRISCO, Texas--(BUSINESS WIRE)--Addus HomeCare Corporation (NASDAQ: ADUS), a provider of home care s
Investors with an interest in Medical - Outpatient and Home Healthcare stocks have likely encountere
Barclays analyst Andrew Mok maintains Addus HomeCare (NASDAQ:ADUS) with a Underweight and lowers
Stephens & Co. analyst Scott Fidel maintains Addus HomeCare (NASDAQ:ADUS) with a Overweight
Barclays analyst Andrew Mok maintains Addus HomeCare (NASDAQ:ADUS) with a Underweight and lowers
BMO Capital analyst Sean Dodge initiates coverage on Addus HomeCare (NASDAQ:ADUS) with a Market P
RBC Capital analyst Ben Hendrix maintains Addus HomeCare (NASDAQ:ADUS) with a Outperform and rais
TD Cowen analyst Ryan Langston maintains Addus HomeCare (NASDAQ:ADUS) with a Buy and raises the p
Barclays analyst Andrew Mok maintains Addus HomeCare (NASDAQ:ADUS) with a Underweight and raises
Companies Reporting Before The Bell • Kosmos Energy (NYSE:KOS) is projected to report quarterly ear
Companies Reporting Before The Bell • HSBC Holdings (NYSE:HSBC) is likely to report earnings for it
Companies Reporting Before The Bell • Immunogen (NASDAQ:IMGN) is estimated to report quarterly loss
Companies Reporting Before The Bell • TG Therapeutics (NASDAQ:TGTX) is estimated to report quarterl